A STUDY ON THE MANAGEMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE

Abstract

Anaemia is a common complication for patients with Chronic Kidney Disease and is associated with cardiovascular comorbidities and reduced Quality of Life. Susceptibility may change depending upon the stage of chronic kidney disease, age, and social habits. A Prospective and Observational study was designed to assess the demographics of patients and variables in Anaemia along with the management of Anaemia in Chronic Kidney Disease. The suspected patient’s blood samples were tested for their Haemoglobin, Erythrocyte Sedimentation Rate, and Packed Cell Volume analysed. Among 115 patients, 79 were males, and 36 were females. 58 patients (50.43%) were identified in the age group >60 years due to diabetes, hypertension and other comorbidities. The patients were given Epoetin Alpha (9.6%) and Iron Sucrose (2.3%) along with Ferrous ascorbate and folic acid (2.7%). In 113 patients (98.3%) and 109 patients (94.78%), the Haemoglobin and Packed Cell Volume were increased due to reduced immune response, comorbidity and severity of Chronic Kidney Disease. Non-pharmacotherapy was provided, and the most common was exercise, meditation (25%), Iron-rich food (2.17%) and a renal low salt diet (1.73%). Follow-up was conducted to check the improvement and found that 95.6% of patients recovered.